Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 2 | 2016 | 2019 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 2 | 2016 | 2019 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.851 | 0.120 | 18 | 63291411 | intron variant | A/G | snv | 0.31 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.120 | 18 | 63291411 | intron variant | A/G | snv | 0.31 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.120 | 18 | 63291411 | intron variant | A/G | snv | 0.31 |
|
Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.120 | 18 | 63291411 | intron variant | A/G | snv | 0.31 |
|
Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2007 | 2012 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Chemically-Induced Disorders | 0.020 | 1.000 | 2 | 2007 | 2007 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2007 | 2012 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2007 | 2012 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Infections | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2001 | 2001 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 |